Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rare and Novel RELA Variants Contribute to Systemic Autoimmunity.

Arthritis & rheumatology (Hoboken, N.J.)·2025
Same author

CD9 expression in minimal change disease and focal segmental glomerulosclerosis.

Clinical kidney journal·2025
Same author

The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial.

Kidney international·2024
Same author

Older patients and dialysis shared decision-making. Insights from an ethnographic discourse analysis of interviews and clinical interactions.

Patient education and counseling·2024
Same author

Shared decision making in chronic kidney disease: a qualitative study of the impact of communication practices on treatment decisions for older patients.

BMC nephrology·2023
Same author

Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial.

Annals of the rheumatic diseases·2023

Related Experiment Video

Updated: Jul 3, 2026

Intravascular Delivery of Biologics to the Rat Kidney
07:29

Intravascular Delivery of Biologics to the Rat Kidney

Published on: September 1, 2016

Interventions for renal vasculitis in adults.

Giles Walters1, Narelle S Willis, Jonathan C Craig

  • 1Renal Department, The Canberra Hospital, PO Box 11, Woden, ACT, Australia, 2606. Giles.Walters@act.gov.au

The Cochrane Database of Systematic Reviews
|July 23, 2008
PubMed
Summary

Plasma exchange effectively reduces end-stage kidney disease in renal vasculitis patients. Continuous cyclophosphamide (CPA) is preferred over pulse CPA to prevent relapses, while azathioprine (AZA) aids maintenance therapy.

Related Experiment Videos

Last Updated: Jul 3, 2026

Intravascular Delivery of Biologics to the Rat Kidney
07:29

Intravascular Delivery of Biologics to the Rat Kidney

Published on: September 1, 2016

Area of Science:

  • Nephrology
  • Immunology
  • Rheumatology

Background:

  • Renal vasculitis, presenting as rapidly progressive glomerulonephritis (RPGN), leads to acute kidney failure (AKF), hematuria, and proteinuria.
  • Standard treatments include steroids and non-steroid agents, often combined with plasma exchange.
  • Despite successful immunosuppression, optimal dosing, duration, and the role of plasma exchange require clarification.

Purpose of the Study:

  • To evaluate the benefits and harms of various interventions for treating renal vasculitis in adults.

Main Methods:

  • A systematic review of randomized controlled trials was conducted.
  • Searches included Cochrane CENTRAL, Cochrane Renal Group Specialised Register, MEDLINE, and EMBASE.
  • Data were independently assessed, with statistical analyses using random effects models.

Main Results:

  • Plasma exchange significantly reduced the risk of end-stage kidney disease (ESKD) at 3 and 12 months.
  • Pulse cyclophosphamide (CPA) increased remission rates but also relapse risk compared to continuous CPA.
  • Azathioprine (AZA) showed no outcome difference but reduced leukopenia; antibiotics were ineffective for preventing Wegener's relapse.

Conclusions:

  • Plasma exchange is effective for severe acute renal failure (ARF) due to vasculitis.
  • Continuous CPA is favored over pulse CPA for reduced relapse risk, though pulse CPA involves a lower total dose.
  • Cotrimoxazole may prevent vasculitis relapse, and AZA is effective for maintenance therapy post-remission.